Short-term function better with arthroscopic release vs. hydrodilatation for primary frozen shoulder .
A randomized controlled trial of arthroscopic capsular release versus hydrodilatation in the treatment of primary frozen shoulder
J Shoulder Elbow Surg. 2018 Aug;27(8):1401-1406. doi: 10.1016/j.jse.2018.04.00250 patients with idiopathic frozen shoulder were randomized to either arthroscopic capsular release or hydrodilitation under fluoroscopy. Primary outcome was function on the Oxford Shoulder Score, while secondary outcomes included health-related quality of life and shoulder range of motion. Follow-up was scheduled for 6 weeks, 3 months, and 6 months. Results demonstrated significantly greater OSS, range of forward elevation, and range of external rotation in the ACR group compared to the HD group.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
